ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683,622 | -46.1% | 227,874 | -32.8% | 0.00% | – |
| Q2 2023 | $1,268,178 | +104.1% | 339,085 | +82.8% | 0.00% | – |
| Q1 2023 | $621,281 | -79.4% | 185,457 | -70.4% | 0.00% | -100.0% |
| Q4 2022 | $3,013,965 | -16.4% | 626,604 | -1.1% | 0.00% | 0.0% |
| Q3 2022 | $3,604,000 | -11.1% | 633,320 | +10.9% | 0.00% | 0.0% |
| Q2 2022 | $4,053,000 | +127.4% | 570,816 | +131.4% | 0.00% | – |
| Q1 2022 | $1,782,000 | -74.6% | 246,709 | -68.6% | 0.00% | – |
| Q4 2021 | $7,026,000 | -16.1% | 786,024 | +229.1% | 0.00% | – |
| Q3 2021 | $8,373,000 | +115.0% | 238,837 | +31.7% | 0.00% | – |
| Q2 2021 | $3,895,000 | +92.3% | 181,300 | +452.7% | 0.00% | – |
| Q1 2021 | $2,025,000 | – | 32,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |